- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
ERR Agonist (Exercise Mimetic) · Educational Resource
Understanding SLU-PP-332 and Metabolic Research
ERR Agonist (Exercise Mimetic)
(Small Molecule Compound)
Investigational Application
Exercise-pathway, metabolic research
Administration Protocol
Oral, per study protocol
Want to learn more?
A licensed team will reach out to guide you through the research.
Book a consultation →ERR Agonist (Exercise Mimetic) · Educational Resource
Understanding SLU-PP-332 and Metabolic Research
01 — Overview
What is SLU-PP-332?
SLU-PP-332 is a small molecule compound classified as a pan-agonist of the estrogen-related receptors (ERRα, ERRβ, and ERRγ), studied in early-stage preclinical literature as an 'exercise mimetic' research compound.
As a very early-stage investigational compound, SLU-PP-332 has not received regulatory approval for therapeutic use in the Philippines or elsewhere, and much of the existing literature is limited to laboratory and animal-model research.
Within research literature, SLU-PP-332 is most frequently studied for its relationship to exercise-pathway signaling and metabolic rate, areas summarized further below.
02 — How it works
How It Works: Estrogen-Related Receptor (ERR) Activation and Exercise-Pathway Signaling
As a pan-agonist of the ERR family of nuclear receptors, SLU-PP-332 is studied for its ability to activate transcriptional pathways that researchers associate with exercise adaptation, without requiring physical exertion in laboratory models.
Literature describes this receptor-activation approach as a novel mechanism distinct from peptide-based or hormone-based compounds, positioning SLU-PP-332 within an emerging small-molecule research category sometimes referred to as 'exercise mimetics.'
Administration in Research
In early-stage preclinical literature, SLU-PP-332 is evaluated primarily via oral administration within controlled laboratory research protocols. As a very early-stage investigational compound, it has not received regulatory approval for therapeutic use, and research contexts differ from any at-home or self-directed use.
03 — Areas of research
Summary of Investigated Research Areas
Early-stage preclinical literature evaluates SLU-PP-332 across several key physiological parameters to map its biological interactions:
ERR Receptor Signaling Pathways
Research literature evaluates how activation of estrogen-related receptors (ERRα/β/γ) influences cellular pathways associated with exercise adaptation.
Mitochondrial Biogenesis Markers
Preclinical studies observe markers of mitochondrial biogenesis following ERR agonist exposure in research models.
Endurance Capacity Parameters
Early-stage literature examines endurance-related physiological parameters in laboratory research models.
Fat Oxidation Studies
Investigational literature reports on fat oxidation measures associated with ERR pathway activation.
Muscle Fiber Type Research
Studies explore relationships between ERR signaling and skeletal muscle fiber composition in preclinical models.
Metabolic Rate Markers
Literature examines indicators of metabolic rate associated with this exercise-mimetic compound class in research settings.
04 — FAQ
Frequently Asked Questions
Ano ba talaga ang SLU-PP-332?
Ang SLU-PP-332 ay isang small molecule compound na tinatawag na “exercise mimetic” dahil pinag-aaralan ito sa laboratory research para sa posibleng pagpapagana ng exercise-related pathways nang walang physical exertion. Educational discussion lang ito, hindi sales o medical advice.
FDA-approved ba ito?
Hindi. Ang SLU-PP-332 ay very early-stage investigational compound na wala pang regulatory approval kahit saan. Karamihan ng literature ay nasa laboratory at animal-model stage pa lamang.
Ano ang ibig sabihin ng "exercise mimetic"?
Tumutukoy ito sa mga compound na pinag-aaralan dahil sa posibleng kakayahang i-activate ang mga cellular pathway na kaugnay ng exercise adaptation, kahit walang aktwal na pisikal na ehersisyo sa research setting.
Pwede ba akong bumili nito dito?
Ang page na ito ay para sa educational purposes lamang. Hindi kami nagbebenta ng peptides o compounds dito online — kausapin ang isang lisensyadong healthcare provider para sa tamang gabay.
05 — References
References and Academic Literature
Billon, C., et al. (2023). Synthetic ERR Agonist SLU-PP-332 Induces an Exercise Mimetic Program in Skeletal Muscle. Nature Communications.
Kilu, W., et al. (2021). Human ERRγ Agonists Reveal a Ligand Recognition Mode Distinct from Its Constitutively Active Counterpart. Journal of Medicinal Chemistry.
Billon, C., et al. (2023). ERRγ Is Required for the Metabolic Adaptations Induced by SLU-PP-332 in Skeletal Muscle. Cell Reports.
i
Medical Education Disclaimer: This page is intended strictly for educational and informational purposes regarding the scientific history and development of chemical compounds. It does not constitute medical advice, promotion, or advertising of any prescription medication. Any therapeutic applications must be evaluated and managed exclusively by a licensed medical practitioner.
Getting started
How to Get Started?
1. Consult
Book a free consultation with our licensed healthcare team.
100 % online. Hassle-free. Convenient.
2. Real Human Assessment
Talk with Philippine-licensed doctors and get prescribed.
Always doctor-led—never just an online form.
Free consultation with licensed providers
3. Start your Program
Your medication is prepared and delivered to your doorstep.
No lock-ins. No hidden fees. No subscriptions.
Formulated in FDA-regulated pharmacies
4. Consistent care
Stay on track with regular weekly follow-ups. On your chosen communication platform.
Unlimited complementary follow-ups